Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

NCT02452190 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Reslizumab
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]